BioSpace News Archive

New research delivers promising signs for nearly 8 million1 adults in the U.S. who suffer from post-traumatic stress disorder (PTSD) each year

Supreme Knight Carl A. Anderson has offered the following response to the Sixth Circuit U.S. Court of Appeals decision to uphold Kentucky’s Ultrasound Informed Consent Act, which requires abortion doctors to show ultrasound images of a baby to the mother.

The birth of the first healthy baby through the pioneering Maternal Spindle Transfer method – implemented for the first time by the Institute of Life and Embryotools – is a global first, offering the potential to preserve the mother’s genetic material.

Recognizing the potential of new technology for enhanced contamination control in cleanrooms where pharmaceuticals are made, RevDesinfectie Robots recently evaluated Xenex Disinfection Systems’ pulsed xenon ultraviolet (UV) light disinfection robots in live production cleanrooms.

When we are hungry we call Grubhub, DoorDash and others that deliver within few hours. But, when we need CBD products, we are forced to find the nearest store or order online.

Internationally recognized diabetes expert, first JDRF CEO with T1D will lead next phase of focused effort to end type 1 diabetes

The Biomedical Advanced Research and Development Authority (BARDA) collaborates with JLABS to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases with residency at JLABS @ Washington, DC

Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, officially released the latest version of their product, Equicare CS 4.10.

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 first quarter operational and financial results after market hours on May 9, 2019

Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today reported financial results for its second quarter of fiscal year 2019, the period ended February 28, 2019 (2QFY19).